The latest in health it & security: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Electronic Clinical Pathway Aims to Close the Obesity Hypoventilation Syndrome Diagnosis Gap in Hospitals.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate from a recent acquisition. The post Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder appeared first on MedCity News.
The Antibiotics Exist —The System Cannot Deliver Them
This is not a discovery problem. It is a market entry and access problem, and it is far more tractable than the pipeline crisis we spend most of our attention on. The post The Antibiotics Exist —The System Cannot Deliver Them appeared first on MedCity News.
Follow the full firehose on the HTC Wire, refreshed automatically every day.